Ocular Diagnosis Of Alzheimer's Disease

Abstract

The invention features a method of diagnosing or providing a prognosis regarding the state of Alzheimer's Disease in a mammal by contacting an ocular tissue with a detectably-labeled compound, which binds to an amyloid protein. An increase in binding of the compound to the ocular tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 20, 2007
  • Application: Nov 18, 2003
    US US 71577603 A
  • Priority: Nov 18, 2003
    US US 71577603 A
  • Priority: Mar 5, 2003
    US US 45233603 P
  • Priority: Nov 18, 2002
    US US 42715302 P
  • Priority: Apr 25, 2002
    US US 13277902 A
  • Priority: Aug 21, 2001
    US US 93512601 A
  • Priority: Apr 27, 2001
    US US 28712401 P
  • Priority: Aug 21, 2000
    US US 22659000 P

Sign in to the Lens

Feedback